NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 81 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 2,040.10 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,557,000 | -43.8% | 6,704,067 | 0.0% | 0.02% | -54.7% |
| Q1 2016 | $6,332,000 | -29.0% | 6,704,067 | 0.0% | 0.05% | -23.2% |
| Q4 2015 | $8,916,000 | -41.7% | 6,704,067 | +0.0% | 0.07% | -40.0% |
| Q3 2015 | $15,281,000 | +41.6% | 6,702,002 | 0.0% | 0.12% | +101.8% |
| Q2 2015 | $10,790,000 | +1.3% | 6,702,002 | 0.0% | 0.06% | -10.9% |
| Q1 2015 | $10,656,000 | -15.9% | 6,702,002 | 0.0% | 0.06% | -21.0% |
| Q4 2014 | $12,667,000 | +43.2% | 6,702,002 | 0.0% | 0.08% | +125.0% |
| Q3 2014 | $8,847,000 | +8.7% | 6,702,002 | +21.9% | 0.04% | -14.3% |
| Q2 2014 | $8,140,000 | -20.0% | 5,500,000 | 0.0% | 0.04% | -4.5% |
| Q1 2014 | $10,175,000 | +92.7% | 5,500,000 | +83.3% | 0.04% | +69.2% |
| Q4 2013 | $5,280,000 | +99.2% | 3,000,000 | +200.0% | 0.03% | +100.0% |
| Q3 2013 | $2,650,000 | -2.8% | 1,000,000 | -2.1% | 0.01% | +8.3% |
| Q2 2013 | $2,727,000 | – | 1,021,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|